The Effect of Prucalopride on the Plasma Levels of Oral Contraceptives (Ethinylestradiol and Norethisterone) in Healthy Subjects.

Trial Profile

The Effect of Prucalopride on the Plasma Levels of Oral Contraceptives (Ethinylestradiol and Norethisterone) in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Mar 2013

At a glance

  • Drugs Ethinylestradiol/norethisterone; Prucalopride
  • Indications Constipation; Menopausal syndrome; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors Shire-Movetis NV
  • Most Recent Events

    • 26 Aug 2010 According to a Movetis media release, data from this study were used as part of the EMA post-marketing commitments made by Movetis at the time of the drug's European approval in May 2010.
    • 08 Jun 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jun 2010 Actual initiation date (Dec 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top